Product Images Glycophos

This appears to be a list of product codes and their corresponding volume (i.e., 1sm, 15mL, 50mL) and manufacturers (e.g., Pfizer, Fresenius Kabi, American Regent) for various medical products. However, it is not clear what the context or purpose of this list is.*

Glycophos™ is a sterile concentrate used for injection after dilution. It contains 1.0 mmol of phosphate and 2.0 mmol of sodium per 1 mL. It is indicated that it should not be injected undiluted. The manufacturer is Fresenius Kabi, and the batch number is LYV 1963 01-67-07-005. The expiration date is not available.*

Glycophos is a sterile concentrate in 20 ml vials manufactured by Fresenius Kabi in Norway and distributed by their division in Sweden. It is an additive meant to be mixed in infusion fluids and contains sodium glycerophosphate, hydrochloric acid, and water for injections. Each mL contains 1.0 mmol of phosphate and 2.0 mmol of Sodium. The warning advises against injecting undiluted and keeping it away from children while storing below 25 °C and not freezing. The document includes a manufacturing date and lot number with specific use-before instructions.*

Glycophos is an organic phosphate solution with 1 mMol of phosphate per 1 mL, which is different from the inorganic phosphate injection products marketed in the U.S. with 3 mMol of phosphate per 1 mL. It does not contain preservatives, is intended for single-use with strict aseptic technique, and is contraindicated for patients with particular medical conditions. The aluminum content of Glycophos is less than 550 meg/L, and its container closure is not made from natural rubber latex. The product comparison table highlights the key differences in strength, formulation, and labeling between phosphate injection products currently available in the U.S. and Glycophos. The barcodes on Glycophos products are not appropriate for scanning systems in the United States and should not be used. Instead, alternative procedures must be followed to ensure that the correct drug product is given to individual patients.*